Market Cap 2.36B
Revenue (ttm) 17.20M
Net Income (ttm) -102.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -593.84%
Debt to Equity Ratio 0.20
Volume 487,400
Avg Vol 225,490
Day's Range N/A - N/A
Shares Out 128.00M
Stochastic %K 83%
Beta 2.30
Analysts Strong Sell
Price Target $27.00

Company Profile

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease and biologic ref...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9639 6036
Fax: 61 3 9639 6030
Address:
55 Collins Street, Level 38, Melbourne, Australia
Shahr_
Shahr_ Oct. 3 at 7:59 PM
$MESO in 50-60s by yr end
0 · Reply
highnihilism
highnihilism Oct. 3 at 5:17 PM
$MESO Mesoblast Trades: 155 | Total $: 424.9 K | 1.84 × 90-Day Avg $: 230.4 K | Call $: 419.8 K | Put $: 5.2 K | Single-Leg: 56% | Multi-Leg: 44% $NVS Novartis Trades: 185 | Total $: 518.9 K | 1.38 × 90-Day Avg $: 376.7 K | Call $: 417.4 K | Put $: 101.6 K | Single-Leg: 96% | Multi-Leg: 4% $BUD Anheuser-Busch Inbev Trades: 192 | Total $: 498.8 K | 0.47 × 90-Day Avg $: 1.06 M | Call $: 416.8 K | Put $: 82.1 K | Single-Leg: 97% | Multi-Leg: 3% $HCA HCA Healthcare Trades: 247 | Total $: 526.9 K | 0.30 × 90-Day Avg $: 1.74 M | Call $: 415.7 K | Put $: 111.2 K | Single-Leg: 34% | Multi-Leg: 66%
0 · Reply
DCRMIA
DCRMIA Oct. 3 at 2:43 PM
Get hyped! $MESO 's gonna blow up! 🚀🚀🚀📈📈📈🇺🇸🇺🇸🇺🇸
0 · Reply
Portman62
Portman62 Oct. 3 at 1:34 PM
$MESO ATH on the horizon …
1 · Reply
zipperson
zipperson Oct. 3 at 6:03 AM
$MESO • For the trailing 12 months (as of June 30, 2025), MESO’s revenue is about USD 17.20 million.  • In analyst consensus estimates, revenue for fiscal 2026 is projected at around USD 73.06 million. That’s freaking 4x!!! Can you imagine what it will do with the stock price? Insane is the word!!!!
0 · Reply
Mani86
Mani86 Oct. 3 at 4:13 AM
$MESO Revenues numbers for the quarter not out yet but stock is booming , someone knows something :)
0 · Reply
hots
hots Oct. 2 at 11:50 AM
$MESO Imagine 4 years from today and GG helping drive a commercial roll out of back pain stem cell treatment through out patient facilities. That could be a massive amount of FCF. GG you are a baller
2 · Reply
highnihilism
highnihilism Sep. 30 at 7:57 AM
$ONTO Onto Innovation: 148 trades, $282K vs $1.92M avg (0.15x). $254K calls / $29K puts. 98% single-leg. $MESO Mesoblast: 183 trades, $255K vs $225K avg (1.13x). $253K calls / $2K puts. 79% single-leg. $KEY Keycorp: 773 trades, $1.07M vs $872K avg (1.22x). $252K calls / $814K puts. 34% single-leg. $TSCO Tractor Supply: 217 trades, $329K vs $469K avg (0.70x). $250K calls / $78K puts. 20% single-leg.
0 · Reply
SweepCastApp
SweepCastApp Sep. 29 at 9:02 AM
$MESO: Unusual Options Activity Alerted CALL flow observed 49x contracts at Strike price of $7 Exp on 01/16/2026 with Premium of $44K and showing BULLISH Sentiment
0 · Reply
Mani86
Mani86 Sep. 26 at 9:01 AM
$MESO https://www.crweworld.com/article/news-provided-by-globenewswire/3719508/mesoblast-cell-therapy-products-are-designated-us-origin-and-not-subject-to-tariffs
0 · Reply
Latest News on MESO
Mesoblast Limited (MESO) Q4 2025 Earnings Call Transcript

Aug 29, 2025, 12:27 PM EDT - 5 weeks ago

Mesoblast Limited (MESO) Q4 2025 Earnings Call Transcript


Successful Commercial Launch of Ryoncil®

Jul 17, 2025, 8:38 PM EDT - 2 months ago

Successful Commercial Launch of Ryoncil®


Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

Apr 28, 2025, 7:44 PM EDT - 5 months ago

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board


First Three Children to Commence Treatment With Ryoncil®

Mar 30, 2025, 7:39 PM EDT - 6 months ago

First Three Children to Commence Treatment With Ryoncil®


Ryoncil® is Now Available for Purchase in the United States

Mar 26, 2025, 8:19 PM EDT - 6 months ago

Ryoncil® is Now Available for Purchase in the United States


Mesoblast Limited (MESO) Q2 2025 Earnings Call Transcript

Feb 28, 2025, 11:38 AM EST - 7 months ago

Mesoblast Limited (MESO) Q2 2025 Earnings Call Transcript


Mesoblast Financial Results and Corporate Update Webcast

Feb 25, 2025, 6:13 PM EST - 7 months ago

Mesoblast Financial Results and Corporate Update Webcast


Dr. Gregory George MD PhD Joins Mesoblast Board

Feb 23, 2025, 6:33 PM EST - 7 months ago

Dr. Gregory George MD PhD Joins Mesoblast Board


Ryoncil® Commercial Launch Update and Product Pipeline

Jan 30, 2025, 7:11 PM EST - 8 months ago

Ryoncil® Commercial Launch Update and Product Pipeline


Mesoblast to be Added to Nasdaq Biotechnology Index

Dec 18, 2024, 7:30 AM EST - 10 months ago

Mesoblast to be Added to Nasdaq Biotechnology Index


Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript

Aug 28, 2024, 9:04 PM EDT - 1 year ago

Mesoblast Limited (MESO) Q4 2024 Earnings Call Transcript


Mesoblast Corporate Presentation at Investor Conference

Jun 2, 2024, 8:23 PM EDT - 1 year ago

Mesoblast Corporate Presentation at Investor Conference


Shahr_
Shahr_ Oct. 3 at 7:59 PM
$MESO in 50-60s by yr end
0 · Reply
highnihilism
highnihilism Oct. 3 at 5:17 PM
$MESO Mesoblast Trades: 155 | Total $: 424.9 K | 1.84 × 90-Day Avg $: 230.4 K | Call $: 419.8 K | Put $: 5.2 K | Single-Leg: 56% | Multi-Leg: 44% $NVS Novartis Trades: 185 | Total $: 518.9 K | 1.38 × 90-Day Avg $: 376.7 K | Call $: 417.4 K | Put $: 101.6 K | Single-Leg: 96% | Multi-Leg: 4% $BUD Anheuser-Busch Inbev Trades: 192 | Total $: 498.8 K | 0.47 × 90-Day Avg $: 1.06 M | Call $: 416.8 K | Put $: 82.1 K | Single-Leg: 97% | Multi-Leg: 3% $HCA HCA Healthcare Trades: 247 | Total $: 526.9 K | 0.30 × 90-Day Avg $: 1.74 M | Call $: 415.7 K | Put $: 111.2 K | Single-Leg: 34% | Multi-Leg: 66%
0 · Reply
DCRMIA
DCRMIA Oct. 3 at 2:43 PM
Get hyped! $MESO 's gonna blow up! 🚀🚀🚀📈📈📈🇺🇸🇺🇸🇺🇸
0 · Reply
Portman62
Portman62 Oct. 3 at 1:34 PM
$MESO ATH on the horizon …
1 · Reply
zipperson
zipperson Oct. 3 at 6:03 AM
$MESO • For the trailing 12 months (as of June 30, 2025), MESO’s revenue is about USD 17.20 million.  • In analyst consensus estimates, revenue for fiscal 2026 is projected at around USD 73.06 million. That’s freaking 4x!!! Can you imagine what it will do with the stock price? Insane is the word!!!!
0 · Reply
Mani86
Mani86 Oct. 3 at 4:13 AM
$MESO Revenues numbers for the quarter not out yet but stock is booming , someone knows something :)
0 · Reply
hots
hots Oct. 2 at 11:50 AM
$MESO Imagine 4 years from today and GG helping drive a commercial roll out of back pain stem cell treatment through out patient facilities. That could be a massive amount of FCF. GG you are a baller
2 · Reply
highnihilism
highnihilism Sep. 30 at 7:57 AM
$ONTO Onto Innovation: 148 trades, $282K vs $1.92M avg (0.15x). $254K calls / $29K puts. 98% single-leg. $MESO Mesoblast: 183 trades, $255K vs $225K avg (1.13x). $253K calls / $2K puts. 79% single-leg. $KEY Keycorp: 773 trades, $1.07M vs $872K avg (1.22x). $252K calls / $814K puts. 34% single-leg. $TSCO Tractor Supply: 217 trades, $329K vs $469K avg (0.70x). $250K calls / $78K puts. 20% single-leg.
0 · Reply
SweepCastApp
SweepCastApp Sep. 29 at 9:02 AM
$MESO: Unusual Options Activity Alerted CALL flow observed 49x contracts at Strike price of $7 Exp on 01/16/2026 with Premium of $44K and showing BULLISH Sentiment
0 · Reply
Mani86
Mani86 Sep. 26 at 9:01 AM
$MESO https://www.crweworld.com/article/news-provided-by-globenewswire/3719508/mesoblast-cell-therapy-products-are-designated-us-origin-and-not-subject-to-tariffs
0 · Reply
DCRMIA
DCRMIA Sep. 25 at 3:57 PM
$MESO there we go! Don't miss the ride
1 · Reply
zipperson
zipperson Sep. 25 at 3:00 PM
$MESO That dip was a great opportunity to load. See you at $20+!
1 · Reply
Mani86
Mani86 Sep. 25 at 7:57 AM
$MESO Streamlining the cell and gene therapy pathway to approval.
1 · Reply
Mani86
Mani86 Sep. 23 at 2:30 AM
$MESO https://www.openpr.com/news/4192136/global-mesenchymal-stem-cells-market-to-reach-usd-18-5-billion
1 · Reply
Mani86
Mani86 Sep. 22 at 2:41 PM
$MESO Hope everyone is enjoying the ride , if revenue numbers coming higher then expected we might double pretty quickly. 👍👍
0 · Reply
Doozio
Doozio Sep. 20 at 2:16 PM
$MESO no faatch 💣 n yo ready for moar during 🐒🍌🧠⏰♾️
0 · Reply
Galilee13
Galilee13 Sep. 20 at 1:49 AM
$MESO huge volume and price jump into the close. Nice!
0 · Reply
zipperson
zipperson Sep. 18 at 10:16 PM
$MESO We just break the $16 resistance. It’s a big deal!
2 · Reply
user1981
user1981 Sep. 18 at 7:05 PM
$MESO whats happening?
0 · Reply
DCRMIA
DCRMIA Sep. 16 at 8:42 PM
$MESO much more is about to come.
0 · Reply
Mani86
Mani86 Sep. 16 at 7:36 AM
$MESO Another director has bought stake above 5%. He is likely a friend of Dr.Gregory George. Surely they have some info that we are yet to get. Future looks good.
0 · Reply
OpenOutcrier
OpenOutcrier Sep. 15 at 12:27 PM
$MESO (+7.3% pre) Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences https://ooc.bz/l/77235
0 · Reply